Posted: 25 October 2021
BioMelbourne Network member, AdAlta Limited, the clinical stage drug discovery company developing novel therapeutic products from its i-body platform is pleased to announce that CEO and Managing Director, Dr Tim Oldham, will present at the upcoming AusBiotech Invest and BIO-Europe Digital conferences taking place virtually from 25-29 October 2021.
Dr Oldham’s presentations will draw on AdAlta’s corporate overview (attached), incorporating results from most recent quarterly report. The presentations focus on AdAlta’s wholly owned fibrosis/inflammation pipeline and co-developed immunooncology pipeline that demonstrate the power of the i-body platform for drug discovery. The video presentations will be available on demand throughout the conferences. The AusBiotech Invest presentation can also be found on the Company’s website at: https://adalta.com.au/investors/presentations/.
Potential investors or partners attending either conference are invited to make contact to arrange 1:1 discussions on AdAlta’s i-body platform, its fibrosis or oncology assets, or for a company introduction. Contact information for Dr Tim Oldham is available at the bottom of this announcement.
AusBiotech Invest 2021
AusBiotech is the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy. AusBiotech Invest is the largest life sciences conference in Australia. Networking and one-to-one meetings for the global life science network are available via this forum. In 2021 AusBiotech Invest will be held virtually from 25-29 October. https://www.ausbiotechnc.org/
BIO-Europe Digital is one of the largest biotech partnering conference in Europe. BIOEurope Digital plays a pivotal role in bringing global biopharma and investment leaders together, to build partnerships that facilitate innovation and medical breakthroughs. In 2021 BIO-Europe will be held digitally from 25-28 October. https://informaconnect.com/bioeurope/